Pharmacokinetic profiles of intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients: A randomized controlled trial
Nicolas De Schryver(Clinique Saint Pierre), Ludovic Gérard(Cliniques Universitaires Saint-Luc), Stéphane Eeckhoudt(Université Libre de Bruxelles), Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), Xavier Wittebole(Cliniques Universitaires Saint-Luc), Nicolas Serck(Clinique Saint Pierre)
Cited by 6
Related Papers
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890